{"disease":{"id":"primary-sj-gren-s-syndrome-pss","name":"primary sj gren s syndrome pss"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06982482","title":"Artificial Intelligence Based Models for Primary Sjögren's Syndrome Diagnosis","phase":"","overall_status":"COMPLETED","enrollment_count":27432,"lead_sponsor_name":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","has_results":false},{"nct_id":"NCT05113004","title":"New Clinical End-points in Patients With Primary Sjögren's Syndrome","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT01782235","title":"Efficacy of Tocilizumab in Primary Sjögren's Syndrome.","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":110,"lead_sponsor_name":"University Hospital, Strasbourg, France","has_results":false},{"nct_id":"NCT07145060","title":"A Study of Yiqi Yangyin Formula in the Treatment of Primary Sjogren's Syndrome","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":105,"lead_sponsor_name":"China-Japan Friendship Hospital","has_results":false},{"nct_id":"NCT03681964","title":"Diagnostic Suspicion of Primitive Syndrome Sjögren's : Brest Cohort","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"University Hospital, Brest","has_results":false},{"nct_id":"NCT06989411","title":"Current Therapy in Primary Sjogren's Syndrome","phase":"NA","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Pamukkale University","has_results":false},{"nct_id":"NCT06862284","title":"Therapeutic Effect of Upadacitinib in Primary Sjögren's Syndrome","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT05269810","title":"Clinical Study to Investigate the Efficacy of Orally Administered SA001 in Patients With Primary Sjögren's Syndrome","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"Samjin Pharmaceutical Co., Ltd.","has_results":false}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}